Clinical Trial Update: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 1]

View source ↗

Summary

Phase 1 evaluation of cisplatin plus paclitaxel in patients with advanced ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Chemotherapeutic Agent Toxicity, Endometrial Adenocarcinoma | Phase 1 | Status: COMPLETED